US3885027A
(en)
*
|
1971-04-12 |
1975-05-20 |
West Laboratories Inc |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
US3896226A
(en)
*
|
1971-11-26 |
1975-07-22 |
Lewinstein Evalina |
6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
|
US3906100A
(en)
*
|
1973-05-24 |
1975-09-16 |
Miles Lab |
N-benzyl-N-{8 2-phenyl-2-(4-phenyl-1-piperidyl)-ethyl{9 -propionamide para-chlorobenzene sulfonate
|
US4048316A
(en)
*
|
1974-03-04 |
1977-09-13 |
Penn Nathar W |
Composition for antagonizing the narcotic effects of barbiturate addiction and withdrawal effects, and for treatment of barbiturate poisoning
|
US4126684A
(en)
*
|
1976-02-11 |
1978-11-21 |
Ciba-Geigy Corporation |
4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
|
US4457933A
(en)
*
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
JPS56128715A
(en)
*
|
1980-03-06 |
1981-10-08 |
Bristol Myers Co |
Analgesic abuse prevention
|
US4366159A
(en)
*
|
1981-09-08 |
1982-12-28 |
Michael Richard Magruder |
Nalbuphine-narcotic analgesic composition and method of producing analgesia
|
DE3216327C1
(de)
*
|
1982-05-03 |
1983-05-19 |
Siempelkamp Gießerei GmbH & Co, 4150 Krefeld |
Herstellung von dickwandigen Abschirmtransport- und Lagerbehältern aus sphärolitischem Gußeisen
|
WO1984000889A1
(fr)
*
|
1982-08-25 |
1984-03-15 |
Joel E Bernstein |
Methode et medicament de traitement du prurit
|
GB8332556D0
(en)
*
|
1983-12-06 |
1984-01-11 |
Reckitt & Colmann Prod Ltd |
Analgesic compositions
|
US4888346A
(en)
*
|
1986-10-07 |
1989-12-19 |
Bernard Bihari |
Method for the treatment of persons infected with HTLV-III (AIDS) virus
|
US5236714A
(en)
*
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
ES2120451T7
(es)
|
1991-09-06 |
2009-11-05 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Composicion que comprende un compuesto de tramadol y acetaminofeno, y su uso.
|
US7027859B1
(en)
|
1994-09-26 |
2006-04-11 |
Alza Corporation |
Electrotransport delivery device having improved safety and reduced abuse potential
|
US5587381A
(en)
*
|
1995-03-27 |
1996-12-24 |
Sinclair; John D. |
Method for terminating methadone maintenance through extinction of the opiate-taking responses
|
AU773642C
(en)
|
1997-12-22 |
2006-04-06 |
Mundipharma Pty Limited |
Opioid agonist/antagonist combinations
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
EP1206264A2
(fr)
*
|
1999-08-25 |
2002-05-22 |
Barrett R. Cooper |
Compositions et procedes permettant de traiter l'intolerance aux opiaces
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
JP2003522144A
(ja)
|
2000-02-08 |
2003-07-22 |
ユーロ−セルティーク,エス.エイ. |
オピオイドアゴニストおよびアンタゴニストを含む制御放出組成物
|
EP1387673B1
(fr)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Forme posologique d'opioides a liberation prolongee empechant la consommation abusive
|
CA2778114A1
(fr)
*
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Forme posologique d'opioides empechant la consommation abusive
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
WO2003002100A1
(fr)
*
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Systeme d'administration de narcotique inviolable
|
ES2319620T3
(es)
|
2001-07-18 |
2009-05-11 |
Euro-Celtique S.A. |
Conbinaciones farmaceuticas de oxicodona y naloxona.
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
SI1414451T1
(sl)
|
2001-08-06 |
2009-10-31 |
Euro Celtique Sa |
Formulacije opioidnega agonista s sproščanja sposobnim in sekvestriranim antagonistom
|
US20030068276A1
(en)
*
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
US20040126428A1
(en)
*
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
ES2733044T1
(es)
*
|
2002-04-05 |
2019-11-27 |
Mundipharma Pharmaceuticals S L |
Composición farmacéutica que contiene oxicodona y naloxona
|
US20030199439A1
(en)
*
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
AR039336A1
(es)
*
|
2002-04-23 |
2005-02-16 |
Alza Corp |
Sistemas analgesicos transdermicos con potencial de abuso reducido
|
US8840928B2
(en)
*
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
EP1594467A4
(fr)
*
|
2002-07-05 |
2008-10-22 |
Collegium Pharmaceutical Inc |
Compositions pharmaceutiques d'opioides et d'autres medicaments empechants les utilisations abusives
|
US8557291B2
(en)
*
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
EP2422775A3
(fr)
*
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Séquestration de sous-unité et compositions et procédés associés
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
EP1615625A4
(fr)
|
2003-04-21 |
2010-12-15 |
Euro Celtique Sa |
Forme posologique inviolable contenant des particules co-extrudees d'agent repulsif contraire et procede de fabrication
|
RS20050812A
(en)
|
2003-04-30 |
2007-12-31 |
Purdue Pharma L.P., |
Tamper resistant transdermal dosage form
|
US20040219195A1
(en)
*
|
2003-04-30 |
2004-11-04 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US7182955B2
(en)
*
|
2003-04-30 |
2007-02-27 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US8790689B2
(en)
*
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
CA2529984C
(fr)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
WO2005044243A2
(fr)
*
|
2003-10-30 |
2005-05-19 |
Alza Corporation |
Systemes analgesiques transdermiques reduisant les risques d'abus de consommation
|
US8883204B2
(en)
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
SI1691892T1
(sl)
*
|
2003-12-09 |
2007-08-31 |
Euro Celtique Sa |
Varnostna koekstrudirana dozirna oblika, ki vsebuje aktivno sredstvo in protisredstvo, in postopek njene izdelave
|
JP2007526796A
(ja)
*
|
2003-12-15 |
2007-09-20 |
アレックザ ファーマシューティカルズ, インコーポレイテッド |
薬剤エアロゾル吸入による突出痛の治療
|
US20050165038A1
(en)
*
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
CA2557839C
(fr)
*
|
2004-03-30 |
2011-05-10 |
Euro-Celtique S.A. |
Forme posologique resistant aux violations, comprenant un absorbant et un agent adverse
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
EP1604667A1
(fr)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement des impatiences des membres inférieurs
|
EP1604666A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement de la bronchopneumopathie chronique obstructive
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
KR20070053267A
(ko)
*
|
2004-08-20 |
2007-05-23 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
반투명 보호 필름을 갖는 경피 약물 전달 장치
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
EP3228308A1
(fr)
*
|
2005-01-28 |
2017-10-11 |
Euro-Celtique S.A. |
Formes posologiques résistantes à l'alcool
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
EP1702558A1
(fr)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Procédé et dispositif pour évaluer la fonction de l'activité intestinale
|
EP1695700A1
(fr)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Forme posologique contenant de l'oxycodone et de la naloxone
|
EP1895995A2
(fr)
*
|
2005-05-13 |
2008-03-12 |
Alza Corporation |
Systeme d'administration de galantamine a couches multiples equipe d'une protection contre l ecoulement un flux de matiere de reservoir
|
WO2006133102A2
(fr)
*
|
2005-06-03 |
2006-12-14 |
Trans-Dermal Patents Company, Llc |
Systeme d'administration d'agent et ses utilisations
|
US20090143761A1
(en)
*
|
2005-06-03 |
2009-06-04 |
Transdermal Patents Company, Llc |
Agent delivery system and uses of same
|
WO2007056142A2
(fr)
*
|
2005-11-02 |
2007-05-18 |
Theraquest Biosciences, Llc |
Procedes de prevention du syndrome serotoninergique et compositions utilisees a cette fin
|
US9125833B2
(en)
*
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
US20090082466A1
(en)
*
|
2006-01-27 |
2009-03-26 |
Najib Babul |
Abuse Resistant and Extended Release Formulations and Method of Use Thereof
|
US8329744B2
(en)
*
|
2005-11-02 |
2012-12-11 |
Relmada Therapeutics, Inc. |
Methods of preventing the serotonin syndrome and compositions for use thereof
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1810670A1
(fr)
*
|
2006-01-19 |
2007-07-25 |
Holger Lars Hermann |
Combinaison de Polamidone et de Naloxone dans le traitement de la toxicomanie
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
EP2007360B1
(fr)
|
2006-04-03 |
2014-11-26 |
Isa Odidi |
Dispositif d'administration à libération commandée comprenant un enrobage organosol
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
CA2655835C
(fr)
|
2006-06-19 |
2015-07-21 |
Alpharma, Inc. |
Compositions pharmaceutiques d'agonistes opioides resistants a l'abus
|
EP1897543A1
(fr)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Gaufre de buprénorphine pour la thérapie de substitution
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
US7748244B2
(en)
*
|
2007-09-14 |
2010-07-06 |
Schlage Lock Company |
Deadbolt lock assembly
|
WO2009059048A2
(fr)
*
|
2007-10-30 |
2009-05-07 |
The Regents Of The University Of Colorado |
Opioïdes-(+) et méthodes d'utilisation
|
US20100239523A1
(en)
*
|
2007-10-30 |
2010-09-23 |
The Regents Of The University Of Colorado |
Tlr modulators and methods for using the same
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
UY32487A
(es)
|
2009-03-10 |
2010-06-30 |
Euro Celtique Sa |
Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CA2827273A1
(fr)
|
2011-02-17 |
2012-08-23 |
QRxPharma Ltd. |
Technologie pour prevenir l'abus de formes pharmaceutiques solides
|
UA116567C2
(uk)
|
2013-07-23 |
2018-04-10 |
Євро-Селтік С.А. |
Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
|
AU2016101552A4
(en)
|
2015-09-03 |
2016-10-13 |
Acino Pharma Ag |
Reduction of the deallylation of naloxone during the storage of a naloxone-containing retard formulation
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
US10532385B2
(en)
|
2016-06-29 |
2020-01-14 |
Disposerx, Inc. |
Disposal of medicaments
|